In
recent years, the exploitation of magnetic nanoparticles in
smart polymeric matrices have received increased attention in several
fields as site-specific drug delivery systems. Here, ultrasonic-assisted
emulsion copolymerization of N-isopropylacrylamide
(NIPAM) and 2-(N,N-diethylaminoethyl) methacrylate (DEAEMA) in the
presence of Fe3O4 nanoparticles was employed
to prepare pH- and temperature-responsive magnetite nanocomposite
particles (MNCPs). The obtained MNCPs were fully characterized by
TEM, DSC, FT-IR, VSM, and XRD techniques. They had an average particle
size of 70 nm with a lower critical solution temperature of 42 °C
and superparamagnetic properties. In addition, MNCPs were loaded with
methotrexate (MTX) as an anticancer drug, and their in vitro drug release was studied in different pH values and temperatures
and in the presence of an alternating magnetic field. Noteworthy that
the highest rate of MTX release was observed at pH 5.5 and 42 °C.
Cell viability of the treated MCF-7 human breast cancer cell line
with free MTX, MNCPs, and MTX-loaded MNCPs or in combination with
magnetic hyperthermia (MHT) and water-based hyperthermia was comparatively
studied. The obtained results showed about 17% higher antiproliferative
activity for the MTX-loaded MNCPs accompanied by MHT relative to that
of free MTX.